These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 7765112)
21. Stationary and microcarrier cell culture processes for propagating Japanese encephalitis virus. Wu SC; Huang GY Biotechnol Prog; 2002; 18(1):124-8. PubMed ID: 11822910 [TBL] [Abstract][Full Text] [Related]
22. Comparison of growth and recombinant protein expression in two different insect cell lines in attached and suspension culture. Taticek RA; Choi C; Phan SE; Palomares LA; Shuler ML Biotechnol Prog; 2001; 17(4):676-84. PubMed ID: 11485429 [TBL] [Abstract][Full Text] [Related]
23. Propagation of Brazilian Zika virus strains in static and suspension cultures using Vero and BHK cells. Nikolay A; Castilho LR; Reichl U; Genzel Y Vaccine; 2018 May; 36(22):3140-3145. PubMed ID: 28343780 [TBL] [Abstract][Full Text] [Related]
24. Rabies virus production in non-woven polyester fabric(NWPF) packed-bed reactors. Gümüşderelioğlu M; Aslankaraoğlu E; Gürhan SI Biotechnol Appl Biochem; 2001 Jun; 33(3):167-72. PubMed ID: 11389670 [TBL] [Abstract][Full Text] [Related]
25. Human amniocyte-derived cells are a promising cell host for adenoviral vector production under serum-free conditions. Silva AC; Simão D; Küppers C; Lucas T; Sousa MF; Cruz P; Carrondo MJ; Kochanek S; Alves PM Biotechnol J; 2015 May; 10(5):760-71. PubMed ID: 25943527 [TBL] [Abstract][Full Text] [Related]
26. Large-scale Vero cell culture on microcarriers in a twenty-liter stirred tank fermentor. Liau MY; Hsiun DY; Li SY; Horng CB; Wu SC Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1996 Aug; 29(3):143-52. PubMed ID: 10592796 [TBL] [Abstract][Full Text] [Related]
27. Rabies virus production in high vero cell density cultures on macroporous microcarriers. Yokomizo AY; Antoniazzi MM; Galdino PL; Azambuja N; Jorge SA; Pereira CA Biotechnol Bioeng; 2004 Mar; 85(5):506-15. PubMed ID: 14760691 [TBL] [Abstract][Full Text] [Related]
28. Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor. Trabelsi K; Rourou S; Loukil H; Majoul S; Kallel H J Biotechnol; 2006 Jan; 121(2):261-71. PubMed ID: 16153733 [TBL] [Abstract][Full Text] [Related]
29. Protein-free culture of Vero cells: a substrate for replication of human pathogenic viruses. Cinatl J; Cinatl J; Rabenau H; Rapp J; Kornhuber B; Doerr HW Cell Biol Int; 1993 Sep; 17(9):885-95. PubMed ID: 8220316 [TBL] [Abstract][Full Text] [Related]
30. Problems with serum-free production of antithrombin III regarding proteolytic activity and product quality. Teige M; Weidemann R; Kretzmer G J Biotechnol; 1994 Apr; 34(1):101-5. PubMed ID: 7764741 [TBL] [Abstract][Full Text] [Related]
31. Influence of culture conditions on recombinant Drosophila melanogaster S2 cells producing rabies virus glycoprotein cultivated in serum-free medium. Batista FR; Moraes AM; Büntemeyer H; Noll T Biologicals; 2009 Apr; 37(2):108-18. PubMed ID: 19059791 [TBL] [Abstract][Full Text] [Related]
32. Formulation and production of a blood-free and chemically defined virus production media for VERO cells. Alfano R; Pennybaker A; Halfmann P; Huang CY Biotechnol Bioeng; 2020 Nov; 117(11):3277-3285. PubMed ID: 32648943 [TBL] [Abstract][Full Text] [Related]
34. Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media. Genzel Y; Olmer RM; Schäfer B; Reichl U Vaccine; 2006 Aug; 24(35-36):6074-87. PubMed ID: 16781022 [TBL] [Abstract][Full Text] [Related]
35. Production of recombinant protein C in serum-containing and serum-free perfusion culture. Sugiura T; Maruyama HB Cytotechnology; 1991 Nov; 7(3):159-64. PubMed ID: 1368118 [TBL] [Abstract][Full Text] [Related]
36. Proteome analysis of virus-host cell interaction: rabies virus replication in Vero cells in two different media. Kluge S; Rourou S; Vester D; Majoul S; Benndorf D; Genzel Y; Rapp E; Kallel H; Reichl U Appl Microbiol Biotechnol; 2013 Jun; 97(12):5493-506. PubMed ID: 23674149 [TBL] [Abstract][Full Text] [Related]
37. Suspension-Vero cell cultures as a platform for viral vaccine production. Paillet C; Forno G; Kratje R; Etcheverrigaray M Vaccine; 2009 Oct; 27(46):6464-7. PubMed ID: 19559123 [TBL] [Abstract][Full Text] [Related]
38. Serum-Free Suspension Culture of MDCK Cells for Production of Influenza H1N1 Vaccines. Huang D; Peng WJ; Ye Q; Liu XP; Zhao L; Fan L; Xia-Hou K; Jia HJ; Luo J; Zhou LT; Li BB; Wang SL; Xu WT; Chen Z; Tan WS PLoS One; 2015; 10(11):e0141686. PubMed ID: 26540170 [TBL] [Abstract][Full Text] [Related]
39. Serum-free production of recombinant proteins and adenoviral vectors by 293SF-3F6 cells. Côté J; Garnier A; Massie B; Kamen A Biotechnol Bioeng; 1998 Sep; 59(5):567-75. PubMed ID: 10099373 [TBL] [Abstract][Full Text] [Related]
40. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture. Genzel Y; Fischer M; Reichl U Vaccine; 2006 Apr; 24(16):3261-72. PubMed ID: 16472544 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]